<DOC>
	<DOCNO>NCT02798497</DOCNO>
	<brief_summary>Staphylococcus aureus express variety virulence factor , include Panton Valentine leukocidin ( PVL ) , cytotoxin . PVL specifically associate primary skin soft-tissue infection severe necrotizing pneumonia ( Gillet et al . Lancet , 2002 ; 359:753-9 ) . PVL-positive S. aureus pneumonia often precede influenza-like symptom , mainly characterized hemoptysis , pleural effusion , rapid onset acute respiratory distress , leukopenia high fatality rate ( 65 % ) ( Gillet et al . Lancet , 2002 ; 359:753-9 ) . Ten year first description disease number controversy scientific literature , question arise whether PVL remain independent factor severity S.aureus pneumonia . In addition , numerous question remain unanswered yet ; : - ( ) factor , include treatment regimen , associate favourable outcome ? , - ( ii ) susceptibility toward antibiotic strain associate disease ? - ( iii ) genetic susceptibility host explain rarity , explosive presentation disease ? To address question prospective observational study nationwide level set . All French hospital invite describe clinical feature new case S. aureus community-acquired pneumonia severity criterion , regardless PVL production . The study include investigation possible innate immune dysfunction collaboration INSERM-U550 ( Génétique Humaine des Maladies Infectieuses , Faculté Necker , Paris ) . Hence , addition collect clinical biological data pneumonia case well strain S. aureus isolate , patient PVL-positive pneumonia sample immune genetic study ( ORFeome sequence functional study )</brief_summary>
	<brief_title>Panton Valentine Leucocidin</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Staphylococcal</mesh_term>
	<criteria>2monthold patient minimum weigh least 5 kg Informed consent Subjects affiliate ( beneficiary ) national medical insurance Presence clinical , biological radiological sign pneumopathy S. aureus whose clinical state justifies hospitalization ICU reanimation Presence PVL positive S.aureus producer ( immunogenetic study ) Patients infected HIV Patients hospitalize 48 hour time diagnosis pneumonia , Patients hospitalize previous three month except outpatient</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>PVL</keyword>
	<keyword>Pneumonias</keyword>
	<keyword>Staphylococcus aureus</keyword>
</DOC>